Delivery Order SPE2DB22D2103-SPE2DB25FR8SD

Award Date 1/7/25
Potential Completion Date 1/8/25
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of VIMPAT 100 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,905.58 and an ultimate completion date of September 28, 2021. The contract was awarded on September 27, 2021, and there was no set-aside designation....
This contract award is for the delivery of VIMPAT 100 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp's Corporate Office division. The contract has a ceiling value of $2,813.85 and is a Firm Fixed Price Delivery Order that runs through August 9, 2024. The award was made on August 8, 2024, and there is no set-aside designation. This contract is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award is for the delivery of VIMPAT 10 MG/ML SOLUTION 200ML pharmaceutical products to the Defense Logistics Agency (DLA), a major defense agency within the U.S. Department of Defense (DoD). The contract, valued at $1,207.93, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on a Firm Fixed Price basis. The contract has a completion date of June 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of VIMPAT 100 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 22, 2022, with a ceiling value of $10,585.23. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug...
This federal contract award is for the delivery of VIMPAT 150 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through December 31, 2025. This single-award IDC serves as the...
This federal contract award, valued at $2,854.18, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of VIMPAT 150 MG TABLET 60S, a pharmaceutical product, with a completion date of January 13, 2025. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIMPAT 200 MG TABLET 60S, a prescription medication, with a ceiling value of $3,318.54 and a completion date of August 8, 2022. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside requirement, indicating it was awarded...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565165565 VIMPAT 100 MG TABLET 60S. The contract has a ceiling value of $1,415.46 and a completion date of July 17, 2024. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen is the prime contractor, and the contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,438.46 firm fixed-price delivery order is for the supply of VIMPAT 100 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of December 18, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award, with a Ceiling Value of $3,747.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award, which is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999, covers the supply of VIMPAT 200 MG TABLET 60S, a medication used for the treatment of certain types of epilepsy. The contract has an Ultimate Completion Date of September 21, 2022 and was awarded...
  • SPE2DB22D2103
    Indefinite Delivery Contract
  • SPE2DB22D2103-SPE2DB25FR8SD
    Delivery Order

This federal contract award is for the delivery of VIMPAT 150 MG TABLET 60S pharmaceutical products to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,336.47 and an ultimate completion date of January 8, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/21/25, 10:20 AM